Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma

References

• RossiGCTinelliCPasinettiGMMilanoGBianchiPEDry eye syndrome-related quality of life in glaucoma patientsEur J Ophthalmol20091957257919551671
   PubMed Web of Science ®Google Scholar
• LeungEWMedeirosFAWeinrebRNPrevalence of ocular surface disease in glaucoma patientsJ Glaucoma20081735035518703943
   PubMed Web of Science ®Google Scholar
• BaudouinCLabbeALiangHPaulyABrignole-BaudouinFPreservatives in eyedrops: the good, the bad and the uglyProg Retin Eye Res20102931233420302969
   PubMed Web of Science ®Google Scholar
• LockingtonDMacdonaldECStewartPYoungDCaslakeMRamaeshKFree radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?Eye (Lond)20122673474122388593
   PubMed Web of Science ®Google Scholar
• BaudouinCHamardPLiangHCreuzot-GarcherCBensoussanLBrignoleFConjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long termOphthalmology20041112186219215582072
   PubMed Web of Science ®Google Scholar
• AriciMKAriciDSTopalkaraAGulerCAdverse effects of topical antiglaucoma drugs on the ocular surfaceClin Experiment Ophthalmol20002811311710933774
   PubMed Web of Science ®Google Scholar
• HerrerasJMPastorJCCalongeMAsensioVMOcular surface alteration after long-term treatment with an antiglaucomatous drugOphthalmology199299108210881495787
   PubMed Web of Science ®Google Scholar
• TuracliEBudakKKaurAMizrakBEkinciCThe effects of long-term topical glaucoma medication on conjunctival impression cytologyInt Ophthalmol19972127339298420
   PubMed Web of Science ®Google Scholar
• PaimelaTRyhanenTKauppinenAMarttilaLSalminenAKaarnirantaKThe preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cellsMol Vis2012181189119622605930
   PubMed Web of Science ®Google Scholar
• FechtnerRDGodfreyDGBudenzDStewartJAStewartWCJasekMCPrevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medicationsCornea20102961862120386433
   PubMed Web of Science ®Google Scholar
• SkalickySEGoldbergIMcCluskeyPOcular surface disease and quality of life in patients with glaucomaAm J Ophthalmol2012153119. e221872203
   PubMed Web of Science ®Google Scholar
• MathewsPMRamuluPYFriedmanDSUtineCAAkpekEKEvaluation of ocular surface disease in patients with glaucomaOphthalmology20131202241224823714318
   PubMed Web of Science ®Google Scholar
• SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the ocular surface disease indexArch Ophthalmol200011861562110815152
   PubMed Web of Science ®Google Scholar
• Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShopOcul Surf2007510815217508118
   PubMed Web of Science ®Google Scholar
• NelsonJDImpression cytologyCornea1988771813280239
   PubMed Web of Science ®Google Scholar
• Van WentCAlalwaniHBrasnuEEvaluation de la sensibilite corneene chez les patients traites medicalement pour un glaucome ou une hypertonie oculaire. [Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension]J Fr Ophtalmol201134684690 French.22093372
   PubMed Web of Science ®Google Scholar
• MartoneGFrezzottiPTosiGMAn in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphologyAm J Ophthalmol2009147725.e1735.e119181302
   PubMed Web of Science ®Google Scholar
• Baffa LdoPRicardoJRDiasACTear film and ocular surface alterations in chronic users of antiglaucoma medicationsArq Bras Oftalmol200871182118408831
   PubMed Web of Science ®Google Scholar
• LeeSYWongTTChuaJBooCSohYFTongLEffect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarityEye (Lond)2013271142115023846375
   PubMed Web of Science ®Google Scholar
• NicholsKKNicholsJJMitchellGLThe lack of association between signs and symptoms in patients with dry eye diseaseCornea20042376277015502475
   PubMed Web of Science ®Google Scholar
• ValenteCIesterMCorsiERolandoMSymptoms and signs of tear film dysfunction in glaucomatous patientsJ Ocul Pharmacol Ther20112728128521557633
   PubMed Web of Science ®Google Scholar
• LiangHPaulyARianchoLBaudouinCBrignole-BaudouinFToxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium systemBr J Ophthalmol20119586987521429894
   PubMed Web of Science ®Google Scholar
• AriciMKAriciDSOzecAVDursunATokerMIErdoganHApoptotic effects of topical antiglaucoma medications on conjunctival epithelium in glaucoma patientsEur J Ophthalmol201424637023787455
   PubMed Web of Science ®Google Scholar
• PisellaPJPouliquenPBaudouinCPrevalence of ocular symptoms and signs with preserved and preservative free glaucoma medicationBr J Ophthalmol20028641842311914211
   PubMed Web of Science ®Google Scholar
• JaenenNBaudouinCPouliquenPManniGFigueiredoAZeyenTOcular symptoms and signs with preserved and preservative-free glaucoma medicationsEur J Ophthalmol20071734134917534814
   PubMed Web of Science ®Google Scholar
• UusitaloHChenEPfeifferNSwitching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medicationActa Ophthalmol20108832933620546237
   PubMed Web of Science ®Google Scholar
• MastropasquaLAgnifiliLFasanellaVConjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology studyActa Ophthalmol201391e397e40523601909
   PubMed Web of Science ®Google Scholar
• Sezgin AkcayBIGuneyEBozkurtTKTopalCSAkkanJCUnluCEffects of polyquaternium- and benzalkonium-chloride-preserved travoprost on ocular surfaces: an impression cytology studyJ Ocul Pharmacol Ther201430754855324901262
   PubMed Web of Science ®Google Scholar
• GhoshSO’HareFLamoureuxEVajpayeeRBCrowstonJGPrevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medicationClin Experiment Ophthalmol20124067568122394358
   PubMed Web of Science ®Google Scholar
• WalkerPMLaneKJOuslerGW3rdAbelsonMBDiurnal variation of visual function and the signs and symptoms of dry eyeCornea20102960761220458235
   PubMed Web of Science ®Google Scholar
• KozobolisVPDetorakisETMaskalerisGCorneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedropsAm J Ophthalmol200513974274315808188
   PubMed Web of Science ®Google Scholar
• PflugfelderSCBaudouinCChallenges in the clinical measurement of ocular surface disease in glaucoma patientsClin Ophthalmol201151575158322125404
   PubMedGoogle Scholar